# Efficacy, Safety and Efficiency of the nMARQ Pulmonary Vein Isolation System in Paroxysmal Atrial Fibrillation

> **NCT02268539** · NA · COMPLETED · sponsor: **Mid and South Essex NHS Foundation Trust** · enrollment: 11 (actual)

## Conditions studied

- Paroxysmal Atrial Fibrillation

## Interventions

- **PROCEDURE:** ablation

## Key facts

- **NCT ID:** NCT02268539
- **Lead sponsor:** Mid and South Essex NHS Foundation Trust
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-02-01
- **Primary completion:** 2017-12-31
- **Final completion:** 2017-12-31
- **Target enrollment:** 11 (ACTUAL)
- **Last updated:** 2020-12-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02268539

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02268539, "Efficacy, Safety and Efficiency of the nMARQ Pulmonary Vein Isolation System in Paroxysmal Atrial Fibrillation". Retrieved via AI Analytics 2026-09-07 from https://api.ai-analytics.org/clinical/NCT02268539. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*